Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.9
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 26620801
Kore RA, Abraham EC (2016) Phosphorylation negatively regulates exosome mediated secretion of cryAB in glioma cells. Biochim Biophys Acta 1863, 368-77 26620801
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S19-p - CRYAB (human)
Modsite: RPFFPFHsPsrLFDQ SwissProt Entrez-Gene
Orthologous residues
CRYAB (human): S19‑p, CRYAB (mouse): S19‑p, CRYAB (rat): S19‑p, CRYAB (rabbit): S19‑p, CRYAB (pig): S19‑p, CRYAB (cow): S19‑p
Characterization
Methods used to characterize site in vivo mutation of modification site, phospho-antibody
Disease tissue studied:  brain cancer, glioblastoma, glioblastoma multiforme, glioma
Relevant cell lines - cell types - tissues:  U-118MG (glial), U373 MG (glial)
Cellular systems studied:  cell lines
Species studied:  human
Downstream Regulation
Effect of modification (function):  intracellular localization
Effect of modification (process):  exocytosis, inhibited

S45-p - CRYAB (human)
Modsite: FPTSTsLsPFYLrPP SwissProt Entrez-Gene
Orthologous residues
CRYAB (human): S45‑p, CRYAB (mouse): S45‑p, CRYAB (rat): S45‑p, CRYAB (rabbit): S45‑p, CRYAB (pig): S45‑p, CRYAB (cow): S45‑p
Characterization
Methods used to characterize site in vivo mutation of modification site, phospho-antibody
Disease tissue studied:  brain cancer, glioblastoma, glioblastoma multiforme, glioma
Relevant cell lines - cell types - tissues:  U-118MG (glial), U373 MG (glial)
Cellular systems studied:  cell lines
Species studied:  human
Downstream Regulation
Effect of modification (process):  exocytosis, inhibited

S59-p - CRYAB (human)
Modsite: PsFLRAPsWFDTGLS SwissProt Entrez-Gene
Orthologous residues
CRYAB (human): S59‑p, CRYAB (mouse): S59‑p, CRYAB (rat): S59‑p, CRYAB (rabbit): S59‑p, CRYAB (pig): S59‑p, CRYAB (cow): S59‑p
Characterization
Methods used to characterize site in vivo mutation of modification site, phospho-antibody
Disease tissue studied:  brain cancer, glioblastoma, glioblastoma multiforme, glioma
Relevant cell lines - cell types - tissues:  U-118MG (glial), U373 MG (glial)
Cellular systems studied:  cell lines
Species studied:  human
Downstream Regulation
Effect of modification (process):  exocytosis, inhibited

T170-gl - CRYAB (human)
Modsite: REEkPAVtAAPKK__ SwissProt Entrez-Gene
Orthologous residues
CRYAB (human): T170‑gl, CRYAB (mouse): A170‑gl, CRYAB (rat): T170‑gl, CRYAB (rabbit): T170‑gl, CRYAB (pig): T170‑gl, CRYAB (cow): T170‑gl
Downstream Regulation
Effect of modification (process):  exocytosis, induced